N
eisseria gonorrhoeae is a strict human pathogen that has caused the sexually transmitted infection termed gonorrhea for thousands of years. Over the millennia, N. gonorrhoeae has developed multiple mechanisms to resist innate host defenses, including cationic antimicrobial peptides/proteins (CAMPs) produced by phagocytes and epithelial cells (1) . Phosphoethanolamine (PEA) decoration of the lipid A possessed by N. gonorrhoeae and N. meningitidis has been shown to contribute to their resistance to CAMPs by a mechanism that likely involves a reduction in ionic interactions of CAMPs with the bacterial surface (1-6), resistance of N. gonorrhoeae to complement-mediated killing by normal human serum (3, 4) , N. gonorrhoeae fitness during experimental infection in mice and humans (5, 7) , and the proinflammatory potential of N. gonorrhoeae (7, 8) . Most commensal Neisseria do not encode lptA (8) , but N. gonorrhoeae and N. meningitidis (2, 3, 8) typically contain lptA and produce multiple isoforms of lipid A that differ in PEA decoration at the 4= and/or 1 position, though the basis of these isoforms has not been fully defined. We now provide evidence that gonococcal lptA is within an operon and that N. gonorrhoeae resistance to a model CAMP (polymyxin B; PMB) is modulated by high-frequency mutation due to a phase-variable (PV) polynucleotide stretch in the lptA coding sequence.
Organization and expression of the lptA locus in N. gonorrhoeae. Bioinformatic analysis of the DNA sequence of the N. gonorrhoeae FA 1090 chromosome (http://www.genome.ou.edu /gono.html) suggested that lptA is transcriptionally linked to two upstream genes (serC and a hypothetical gene annotated as NGO1282) and a downstream gene (nfnB) (Fig. 1 ). This hypothesis was confirmed by results from reverse transcription-PCR (RT-PCR) experiments ( Fig. 2A ) that demonstrated transcriptional linkage of lptA with the serC, hypothetical, and nfnB genes; details of the experimental procedures and a list of oligonucleotide primers are provided in the legends of Fig. 1 and 2 and in Table 1 , respectively. However, primer extension analysis of total N. gonorrhoeae RNA performed as described previously (9) identified a transcriptional start point (TSP) positioned 61 nucleotides (nt) upstream of the lptA translational start codon and four nt downstream of near-consensus Ϫ10 and Ϫ35 elements ( Fig. 1 and 2B ). Thus, we tentatively conclude that lptA expression in N. gonorrhoeae can be initiated by two promoters upstream of serC and lptA, respectively. The mechanisms that control use of these promoters are now under investigation.
Analysis of the online FA 1090 genome sequence indicated that the lptA coding sequence contains a polynucleotide tract consist- ing of seven Ts (T-7), which would result in production of a truncated LptA enzyme due to a new translational stop codon (Fig. 3) . However, our independent sequencing of a PCR product containing the lptA gene from FA 1090 as well from strain FA19 showed the presence of a T-8 tract (data not presented and Fig. 3A ), which would result in production of a full-length LptA enzyme (Fig. 3B) . Moreover, analysis of the online (http://www.broadinstitute .org/annotation/genome/neisseria_gonorrhoeae/GenomesIndex .html) whole-genome sequences of 13 other gonococcal strains indicated that their lptA gene contains the T-8 tract (data not presented). In addition, the genome sequence for 73 N. gonorrhoeae clinical isolates from patients with symptomatic gonorrhea was determined using Illumina technology; the details of this genome shotgun sequencing effort will be published separately. The nucleotide sequence of the FA19 lptA gene was searched against a BLAST database of all the whole-genome de novo-assembled contigs of these clinical isolates using BLASTN in WUBLAST, in order to identify the genome location of the gene within each of the strains. We used the default blastn parameters and specified hspsepSmax (maximum separation allowed between HSPs [highscoring segment pair] along subject) to be 100 bp. Sequences of lptA genes were then extracted and screened for the presence of a T-8 tract on both the forward and reverse strands of the gene using pattern matching. The results showed that all strains contained a T-8 tract and a full-length lptA sequence with 100% nucleotide identity to FA 1090 (data not presented). Accordingly, we propose that possession of an in-frame lptA gene is a common feature of N. gonorrhoeae isolates.
lptA behaves as a PV gene in N. gonorrhoeae, and phase-off variants are hypersusceptible to PMB. The presence of the T-8 tract in the 5= end of the lptA coding sequence suggested to us that it is a member of the PV gene family possessed by N. gonorrhoeae (10) . If so, production of a full-length LptA, PEA decoration of lipid A, and CAMP resistance could differ within a population of gonococci. To test this possibility, we employed a PMB screen/ selection procedure since loss of lptA expression renders N. gonorrhoeae hypersusceptible to this model CAMP (3, 5, 7) . After replica plating approximately 3,000 colonies of strain FA 1090 (T-8 tract and PMB MIC of 100 g/ml) onto gonococcal base (GCB) agar plates with or without PMB selection, we identified (approximate frequency of 3.3 ϫ 10 Ϫ4 ) a colony (strain BB22) that was unable to grow on GCB agar plates containing 10 g/ml RNA harvested (RNeasy minikit; Qiagen) from a log-phase culture of strain FA19 grown as described previously (9) . First-strand cDNA was generated using SuperScript II reverse transcriptase (Invitrogen) and a gene-specific reverse primer (LptA8) that binds in the nfnB gene and primes elongation of a singlestranded cDNA toward serC. PCR was then performed to confirm transcriptional linkage between pairs of genes. Sections A, B, and C of the gel are grouped by forward-and reverse-primer locations and separated by 1-kb PLUS DNA ladders (Invitrogen). Lane 1, FA19 cDNA; lane 2, ϪRT negative control (RT omitted); lane 3, FA19 genomic DNA positive control; lane 4, no-template negative control. Section A, "serC" ϭ serC_F; "NGO1282" ϭ NGEG_02068_R. Section B, "serC" ϭ serC_F; "lptA" ϭ lptArev. Section C, "lptA" ϭ LptA6; "nfnB" ϭ LptA8. (B) Primer extension of the lptA transcript. Primer extension analysis was performed as described previously (9) using 20 g of FA19 total RNA as the template and a radioactively ([␥-32 P]ATP) labeled reverse primer (LptA7_R) that anneals 67 bp downstream of the lptA start codon. RNA was purified and cDNA generated as described for panel A. Radioactive single-stranded cDNA products were separated on a polyacrylamide gel alongside sequencing reactions that used the same reverse primer (LptA11 was the forward primer used for generation of the sequenced lptA promoter template). The TSP corresponds to the band labeled with an asterisk and is 4 bp downstream of a consensus 70 -type Ϫ10 element. A second band appeared running approximately 4 to 5 nucleotides shorter than the proposed ϩ1 TSP band and could be due to a degraded mRNA transcript.
TABLE 1 Oligonucleotide primers used in this study

Primer name
Primer sequence Purpose LptA6 5=-CGGTTTTGTATGTGGATCAGTT-3= Transcriptional linkage LptA7 5=-GCCTTTCTTTCCCTGTATTCTT-3= Sequencing of the poly-T tract LptA7_R 5=-AAGAATACAGGGAAAGAAAGGC-3= Primer extension LptA8 5=-ACGTTGCAATCCTACCTCGC-3= Transcriptional linkage LptA11 5=-CCGGTTCGAATTTTGCTTACG-3= Primer extension LptAdelL 5=-TGCAGGTACATCATGAAATTAGAC-3= Sequencing of the poly-T tract lptAJK4 5=-TAAGAATCTTTTTCAATAATCCGGAT-3= Sequencing of the poly-T tract lptArev 5=-GCCTCAGGTTCGGTTTTATC-3= Transcriptional linkage LptAstart 5=-TCTAGAAAGCTTCATCGACTTGT-3= Sequencing of the poly-T tract NGEG_02068_R 5=-GCGGGCAAAGCATTTCATAT-3= Transcriptional linkage serC_F 5=-CGACTACGGACTGATTTACG-3= Transcriptional linkage
Phase-Variable Antimicrobial Peptide Resistance of PMB. The PMB MIC against BB22 was 0.2 g/ml (Fig. 3A) , which is similar to the PMB MIC against an lptA deletion mutant of FA 1090 described previously (5) . DNA sequence analysis of the lptA sequence of BB22 revealed that it possessed a T-9 tract that would result in premature truncation of LptA (Fig. 3) . We then selected for spontaneous variants of BB22 that would grow on GCB agar containing 10 g/ml of PMB. In four separate experiments, spontaneous PMB-resistant variants arose at a frequency of approximately 10 Ϫ5 ; in contrast, spontaneous erythromycinresistant mutants (selected at 1 g/ml) were recovered at a frequency of 10 Ϫ8 (data not presented). The PMB MIC against PMBresistant mutants of BB22 was, like that seen with parental strain FA 1090, 100 g/ml (see strain BB22R data in Fig. 3A) . DNA sequencing of the lptA PV tract from sixteen randomly picked PMB-resistant revertants of BB22 showed that all possessed a wild-type T-8 tract (see BB22R in Fig. 3A ) and would produce a full-length LptA (Fig. 3B) . Based on this reversion frequency, we estimate that the poly-T tract in lptA phase varies at an approximate frequency of 10 Ϫ5 . This frequency is 2 to 3 orders of magnitude lower than that seen with other PV genes of N. gonorrhoeae, which may be due to its shorter tract (8 nt) and A/T characteristics that reduce slipped-strand mispairing events compared to the results seen with longer, G/C-rich repeats (10) (11) (12) .
Conclusions. Production of PEA-decorated lipid A by N. gonorrhoeae has been linked with bacterial resistance to mediators of innate host defense, the capacity of N. gonorrhoeae to elicit a proinflammatory response, and in vivo fitness (3-5, 7, 8) . The structurally variable lipooligosaccharide (LOS) chemotypes produced by gonococci have been linked to PV genes that encode enzymes responsible for adding carbohydrates within the branched-chain oligosaccharide region (11, 12) . Our work now extends this PV expression property of LOS to the lipid A isoforms and emphasizes the complexity of LOS structures that can be presented by N. gonorrhoeae. Importantly, to our knowledge, this is the first direct evidence that gonococcal resistance to CAMPs can be modulated by a PV process.
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